These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12045904)

  • 1. Methylprednisolone pulse therapy for patients with dysthyroid optic neuropathy.
    Ph Mourits M; Kalmann R; Sasim IV
    Orbit; 2001 Dec; 20(4):275-280. PubMed ID: 12045904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Therapeutic Effect of Combination of Orbital Decompression Surgery and Methylprednisolone Pulse Therapy on Patients with Bilateral Dysthyroid Optic Neuropathy.
    Xu J; Ye H; Chen G; Chen J; Chen R; Yang H
    J Ophthalmol; 2020; 2020():9323450. PubMed ID: 32148948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy.
    Currò N; Covelli D; Vannucchi G; Campi I; Pirola G; Simonetta S; Dazzi D; Guastella C; Pignataro L; Beck-Peccoz P; Ratiglia R; Salvi M
    Thyroid; 2014 May; 24(5):897-905. PubMed ID: 24417307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy.
    Miśkiewicz P; Rutkowska B; Jabłońska A; Krzeski A; Trautsolt-Jeziorska K; Kęcik D; Milczarek-Banach J; Pirko-Kotela K; Samsel A; Bednarczuk T
    Endokrynol Pol; 2016; 67(2):166-73. PubMed ID: 26884288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysthyroid Optic Neuropathy: Treatment with Additional Intravenous Methylprednisolone Pulses after the Basic Schedule Is Associated with Stabilization or Further Improvement of Clinical Outcome.
    Pelewicz M; Rymuza J; Pelewicz K; Miśkiewicz P
    J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy.
    Kemchoknatee P; Tangon D; Srisombut T
    BMC Ophthalmol; 2023 Jan; 23(1):32. PubMed ID: 36690985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic outcomes and influence factors of maximal orbital decompression in the treatment of severe dysthyroid optic neuropathy].
    Wang Y; Li YY; Yang N; Ma R; Xiao LH
    Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):416-423. PubMed ID: 28606262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study.
    Sears CM; Wang Y; Bailey LA; Turbin R; Subramanian PS; Douglas R; Cockerham K; Kossler AL
    Am J Ophthalmol Case Rep; 2021 Sep; 23():101111. PubMed ID: 34113737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
    Juri J; Stiglmayer N; Kuzman T
    Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Treatment of Dysthyroid Optic Neuropathy: Long-Term Visual Outcomes with Comparison of 2-Wall versus 3-Wall Orbital Decompression.
    Korkmaz S; Konuk O
    Curr Eye Res; 2016; 41(2):159-64. PubMed ID: 25835051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysthyroid Optic Neuropathy.
    Saeed P; Tavakoli Rad S; Bisschop PHLT
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S60-S67. PubMed ID: 29927882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysthyroid optic neuropathy: atypical initial presentation and persistent visual loss.
    Mensah A; Vignal-Clermont C; Mehanna C; Morel X; Galatoire O; Jacomet PV; Morax S
    Orbit; 2009; 28(6):354-62. PubMed ID: 19929659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.
    McKeag D; Lane C; Lazarus JH; Baldeschi L; Boboridis K; Dickinson AJ; Hullo AI; Kahaly G; Krassas G; Marcocci C; Marinò M; Mourits MP; Nardi M; Neoh C; Orgiazzi J; Perros P; Pinchera A; Pitz S; Prummel MF; Sartini MS; Wiersinga WM;
    Br J Ophthalmol; 2007 Apr; 91(4):455-8. PubMed ID: 17035276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical coherence tomography measurements in compressive optic neuropathy associated with dysthyroid orbitopathy.
    Park KA; Kim YD; In Woo K; Kee C; Han JC
    Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1617-1624. PubMed ID: 27169807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcaruncular orbital decompression for dysthyroid optic neuropathy.
    Perry JD; Kadakia A; Foster JA
    Ophthalmic Plast Reconstr Surg; 2003 Sep; 19(5):353-8. PubMed ID: 14506419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into Current Management Strategies for Dysthyroid Optic Neuropathy: A Review.
    Tagami M; Honda S; Azumi A
    Clin Ophthalmol; 2022; 16():841-850. PubMed ID: 35330749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Outcomes of Balanced Orbital Decompression for Dysthyroid Optic Neuropathy: Focusing on Choroiretinal Folds with and without Optic Disc Edema.
    Zeng P; Deng XW; Tian P; Peng YY; Xu MT; Zhou SY; Wang M
    Dis Markers; 2023; 2023():9503821. PubMed ID: 36865501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysthyroid optic neuropathy: Demographics, risk factors, investigations, and management outcomes.
    Poonam NS; Alam MS; Oberoi P; Mukherjee B
    Indian J Ophthalmol; 2022 Dec; 70(12):4419-4426. PubMed ID: 36453357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics of dysthyroid optic neuropathy].
    Elyashiv S; Skaat A; Ben Simon G; Huna-Baron R
    Harefuah; 2015 Feb; 154(2):98-102, 137. PubMed ID: 25856861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.